Novartis

Novartis to split pharmaceuticals division into two business units

18 May 2016

Swiss drugmaker Novartis AG yesterday said that it is splitting its pharmaceuticals division into two business units, Novartis Pharmaceuticals and Novartis Oncology

Novartis under criminal investigation in S Korea for offering kickbacks to doctors

25 Apr 2016

Novartis to sell stake in Roche worth $13.8 bn

25 Apr 2016

Sun Pharma in talks to buy Novartis’ Japan portfolio

14 Nov 2015

GSK to sell its multiple sclerosis treatment drug to Novartis for $1 bn

21 Aug 2015

Novartis to sell new heart failure drug for 80 per cent more than projected

09 Jul 2015

US claims $3.3 bn in Novartis kickback lawsuit

01 Jul 2015

Novartis is accused of referring patients to specialty pharmacies and paying kickbacks in the form of rebates to get them to recommend the drugs to patients to boost sales

Novartis to buy chronic pain drug developer Spinifex Pharmaceuticals

29 Jun 2015

Founded in 2005 and based in Stamford, Connecticut, USA, and Melbourne, Australia, Spinifex’ lead product is EMA401, under development as a potential first-in-class oral treatment for chronic pain without CNS side effects

HC backs Novartis, bars Cipla from selling lung drug copy

By By Jagdeep Worah | 10 Jan 2015

In a blow to those suffering from lung and respiratory diseases, the Delhi High Court on Friday restrained domestic firm Cipla from marketing its affordable generic version of respiratory drug Onbrez, ruling in favour of multinational Novartis